155 related articles for article (PubMed ID: 28898233)
41. Differences in cancer survival by area-level socio-economic disadvantage: A population-based study using cancer registry data.
Afshar N; English DR; Blakely T; Thursfield V; Farrugia H; Giles GG; Milne RL
PLoS One; 2020; 15(1):e0228551. PubMed ID: 31999795
[TBL] [Abstract][Full Text] [Related]
42. Histological subtype of lung cancer in relation to socio-economic deprivation in South East England.
Bennett VA; Davies EA; Jack RH; Mak V; Møller H
BMC Cancer; 2008 May; 8():139. PubMed ID: 18489782
[TBL] [Abstract][Full Text] [Related]
43. Relative survival in elderly European cancer patients: evidence for health care inequalities. The EUROCARE Working Group.
Vercelli M; Capocaccia R; Quaglia A; Casella C; Puppo A; Coebergh JW
Crit Rev Oncol Hematol; 2000 Sep; 35(3):161-79. PubMed ID: 10960799
[TBL] [Abstract][Full Text] [Related]
44. Cancer incidence rates in Turkey in 2006: a detailed registry based estimation.
Eser S; Yakut C; Özdemir R; Karakilinç H; Özalan S; Marshall SF; Karaoğlanoğlu O; Anbarcioğlu Z; Üçüncü N; Akin Ü; Özen E; Özgül N; Anton-Culver H; Tuncer M
Asian Pac J Cancer Prev; 2010; 11(6):1731-9. PubMed ID: 21338224
[TBL] [Abstract][Full Text] [Related]
45. More 'malignant' than cancer? Five-year survival following a first admission for heart failure.
Stewart S; MacIntyre K; Hole DJ; Capewell S; McMurray JJ
Eur J Heart Fail; 2001 Jun; 3(3):315-22. PubMed ID: 11378002
[TBL] [Abstract][Full Text] [Related]
46. Temporal Trends in Population-Level Cure of Cancer: The Australian Context.
Kou K; Dasgupta P; Cramb SM; Yu XQ; Baade PD
Cancer Epidemiol Biomarkers Prev; 2020 Mar; 29(3):625-635. PubMed ID: 31932416
[TBL] [Abstract][Full Text] [Related]
47. Socio-economic inequalities in survival of patients with prostate cancer: role of age and Gleason grade at diagnosis.
Shafique K; Morrison DS
PLoS One; 2013; 8(2):e56184. PubMed ID: 23418534
[TBL] [Abstract][Full Text] [Related]
48. Socioeconomic status and site-specific cancer incidence, a Bayesian approach in a French Cancer Registries Network study.
Bryere J; Dejardin O; Launay L; Colonna M; Grosclaude P; Launoy G;
Eur J Cancer Prev; 2018 Jul; 27(4):391-398. PubMed ID: 27879493
[TBL] [Abstract][Full Text] [Related]
49. Cancer prevalence in Central Europe: the EUROPREVAL Study.
Lutz JM; Francisci S; Mugno E; Usel M; Pompe-Kirn V; Coebergh JW; Bieslka-Lasota M;
Ann Oncol; 2003 Feb; 14(2):313-22. PubMed ID: 12562661
[TBL] [Abstract][Full Text] [Related]
50. Assessing the impact of socio-economic status on cancer survival in New South Wales, Australia 1996-2001.
Yu XQ; O'Connell DL; Gibberd RW; Armstrong BK
Cancer Causes Control; 2008 Dec; 19(10):1383-90. PubMed ID: 18704715
[TBL] [Abstract][Full Text] [Related]
51. Breast, lung and colorectal cancer incidence and survival in South Thames Region, 1987-1992: the effect of social deprivation.
Pollock AM; Vickers N
J Public Health Med; 1997 Sep; 19(3):288-94. PubMed ID: 9347452
[TBL] [Abstract][Full Text] [Related]
52. Estimation of life expectancy and the expected years of life lost in patients with major cancers: extrapolation of survival curves under high-censored rates.
Chu PC; Wang JD; Hwang JS; Chang YY
Value Health; 2008 Dec; 11(7):1102-9. PubMed ID: 18489497
[TBL] [Abstract][Full Text] [Related]
53. Person-years of life lost due to cancer in the United States, 1970 and 1984.
Horm JW; Sondik EJ
Am J Public Health; 1989 Nov; 79(11):1490-3. PubMed ID: 2817158
[TBL] [Abstract][Full Text] [Related]
54. Estimates of cancer incidence and mortality in Europe in 1995.
Bray F; Sankila R; Ferlay J; Parkin DM
Eur J Cancer; 2002 Jan; 38(1):99-166. PubMed ID: 11750846
[TBL] [Abstract][Full Text] [Related]
55. Deprivation, stage at diagnosis and cancer survival.
Schrijvers CT; Mackenbach JP; Lutz JM; Quinn MJ; Coleman MP
Int J Cancer; 1995 Nov; 63(3):324-9. PubMed ID: 7591225
[TBL] [Abstract][Full Text] [Related]
56. Lead Time Bias May Contribute to the Shorter Life Expectancy in Post-colonoscopy Colorectal Cancer.
Chen WY; Cheng HC; Cheng WC; Wang JD; Sheu BS
Dig Dis Sci; 2019 Sep; 64(9):2622-2630. PubMed ID: 30835027
[TBL] [Abstract][Full Text] [Related]
57. Expected Years of Life Lost Due to Adult Cancer Mortality in Yazd ( 2004-2010 ).
Mirzaei M; Mirzadeh M; Mirzaei M
Asian Pac J Cancer Prev; 2016; 17(S3):101-5. PubMed ID: 27165216
[TBL] [Abstract][Full Text] [Related]
58. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010.
Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W
JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310
[TBL] [Abstract][Full Text] [Related]
59. Cancer prevalence estimates in Italy from 1970 to 2010.
De Angelis R; Grande E; Inghelmann R; Francisci S; Micheli A; Baili P; Meneghini E; Capocaccia R; Verdecchia A
Tumori; 2007; 93(4):392-7. PubMed ID: 17899871
[TBL] [Abstract][Full Text] [Related]
60. The cancer survival gap between elderly and middle-aged patients in Europe is widening.
Quaglia A; Tavilla A; Shack L; Brenner H; Janssen-Heijnen M; Allemani C; Colonna M; Grande E; Grosclaude P; Vercelli M;
Eur J Cancer; 2009 Apr; 45(6):1006-16. PubMed ID: 19121578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
